Highly Active Antiretroviral Therapy Clinical Trials Highly Active Antiretroviral Therapy RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
Condition:   This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.Intervention:   Sponsors:   The HIV Netherlands Australia Thailand Research Collaboration;   The HIV Netherlands Australia Thailand Research Collaboration;   Commission of higher education (CHE), Ministry of Education, Thailand;   Thai National Health Security Office (NHSO)Active, not recruiting - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2010 Category: Research Source Type: clinical trials

Contingency Management in the Delivery of HAART to Drug Users in Chennai, India
Conditions:   HIV;   Substance Abuse, IntravenousInterventions:   Behavioral: Contingency;   Other: Prize bowl drawingsSponsors:   Johns Hopkins University;   YR Gaitonde Centre for AIDS Research and EducationCompleted - verified February 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2009 Category: Research Source Type: clinical trials

Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions:   HIV Infection;   Osteopenia;   OsteoporosisIntervention:   Sponsors:   Emory University;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2009 Category: Research Source Type: clinical trials

Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions:   HIV Infection;   Osteopenia;   OsteoporosisIntervention:   Sponsors:   Emory University;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2009 Category: Research Source Type: clinical trials

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
Condition:   HIVInterventions:   Drug: HAART;   Drug: HAART + ImmunotherapySponsor:   Juan A. ArnaizCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2009 Category: Research Source Type: clinical trials